J47.9

Bronchiectasis, uncomplicated

Bronchiectasis is a chronic, progressive respiratory condition characterized by the permanent, abnormal dilation of the bronchi and bronchioles. This structural damage is typically the result of a 'vicious cycle' of recurrent inflammation and infection that weakens the elastic and muscular components of the bronchial walls. In the uncomplicated form (J47.9), the condition is present and may be symptomatic, but it is not currently undergoing an acute exacerbation or accompanied by an acute lower respiratory infection. Pathologically, the impaired mucociliary clearance leads to the pooling of mucus, which serves as a nidus for bacterial colonization (most commonly by Haemophilus influenzae or Pseudomonas aeruginosa). Over time, this results in significant remodeling of the airway, potentially leading to obstructive lung disease, impaired gas exchange, and increased risk of respiratory failure.

Clinical Symptoms

Chronic cough, often productive of large volumes of sputum
Daily production of purulent (yellow or green) sputum
Foul-smelling breath (halitosis) related to stagnant mucus
Hemoptysis (blood-streaked sputum or more significant bleeding)
Dyspnea (shortness of breath), particularly on exertion
Wheezing and chest tightness
Pleuritic chest pain
Chronic fatigue and malaise
Coarse crackles and rhonchi heard upon lung auscultation
Digital clubbing (in advanced or long-standing cases)
Frequent bouts of sinusitis
Weight loss and cachexia in severe, end-stage disease

Common Causes

Post-infectious damage (e.g., history of severe pneumonia, pertussis, or measles)
Tuberculosis or non-tuberculous mycobacterial (NTM) infections
Primary Ciliary Dyskinesia (PCD), including Kartagener syndrome
Common Variable Immunodeficiency (CVID) and other immunoglobulin deficiencies
Alpha-1 Antitrypsin Deficiency
Autoimmune diseases such as Rheumatoid Arthritis or Sjögren's Syndrome
Allergic Bronchopulmonary Aspergillosis (ABPA)
Chronic pulmonary aspiration (e.g., from GERD or swallowing disorders)
Congenital airway defects such as Williams-Campbell syndrome
Bronchial obstruction from tumors or foreign bodies
Inflammatory bowel disease (Ulcerative Colitis or Crohn's Disease)

Documentation & Coding Tips

Distinguish between baseline status and acute changes to ensure correct coding of uncomplicated bronchiectasis versus exacerbation.

Example: Patient with established bronchiectasis presents for a semi-annual review. Respiratory status is at baseline with no increase in cough, sputum volume, or change in sputum purulence. On physical exam, stable coarse crackles are noted in the left lower lobe. No fever or pleuritic chest pain. Diagnosis: Chronic bronchiectasis, uncomplicated (J47.9). Plan: Continue current airway clearance regimen to maintain stability.

Billing Focus: Documentation must specify the absence of acute infection or exacerbation to support the use of J47.9 instead of J47.1 or J47.0.

Document the absence of underlying genetic or systemic causes such as Cystic Fibrosis to justify the use of J47.9.

Example: Evaluated patient for chronic cough and bronchiectasis. Genetic testing for cystic fibrosis and alpha-1 antitrypsin levels are normal. HRCT shows localized cylindrical bronchiectasis in the right middle lobe. Symptoms are stable. Diagnosis: Bronchiectasis, uncomplicated (J47.9). Condition is idiopathic and chronic, requiring daily flutter valve use.

Billing Focus: Excluding Cystic Fibrosis (E84 series) is essential as CF codes take precedence over the J47 series in the coding hierarchy.

Reference specific imaging findings from High-Resolution Computed Tomography to provide clinical evidence for the diagnosis.

Example: HRCT of the chest reveals bronchial wall thickening and a signet-ring sign in the right lower lobe, confirming the diagnosis of bronchiectasis. The patient is currently asymptomatic regarding acute respiratory distress or infection. Diagnosis: Bronchiectasis, uncomplicated (J47.9). Management: Pulmonary hygiene and annual vaccinations for prevention of exacerbations.

Billing Focus: Linking the diagnosis to imaging findings (CT Chest) strengthens the medical necessity for the encounter and the code specificity.

Detail the airway clearance techniques and maintenance medications utilized to manage the chronic condition.

Example: Patient continues to use hypertonic saline nebulization and a chest wall oscillation vest twice daily for management of stable bronchiectasis in both lower lobes. There are no signs of acute lower respiratory infection. Diagnosis: Bronchiectasis, uncomplicated (J47.9). Stable on current maintenance therapy.

Billing Focus: Documentation of ongoing treatment (MEAT criteria: Monitor, Evaluate, Assess, Treat) is required to code a chronic condition during an encounter.

Clarify that the bronchiectasis is not a result of a current congenital anomaly or acute injury.

Example: Patient with a history of childhood pertussis presents with stable chronic bronchiectasis. Imaging shows no evidence of congenital pulmonary sequestration. Diagnosis: Bronchiectasis, uncomplicated (J47.9). Clinical status is stable with clear sputum and no acute distress.

Billing Focus: Distinguishing acquired bronchiectasis from congenital forms (Q33.4) ensures accurate ICD-10-CM code selection.

Relevant CPT Codes

99213 - Office or other outpatient visit for the evaluation and management of an established patient, low level of medical decision making, 20-29 minutes
Used for routine follow-up of stable bronchiectasis where minimal changes to the treatment plan are required.
99214 - Office or other outpatient visit for the evaluation and management of an established patient, moderate level of medical decision making, 30-39 minutes
Appropriate for stable bronchiectasis visits involving the review of recent imaging and adjustment of multiple maintenance therapies.
71250 - Computed tomography, thorax; without contrast material
High-resolution CT (HRCT) is the gold standard for confirming the diagnosis of bronchiectasis and assessing its extent.
94010 - Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation
Used to assess for obstructive or restrictive lung patterns often associated with bronchiectasis.
94667 - Manipulation chest wall, such as percussion and vibration to facilitate lung function; initial demonstration and/or evaluation
Crucial for teaching patients how to clear the excessive mucus produced in bronchiectasis.
31622 - Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; diagnostic, with or without cell washing
Performed to rule out endobronchial lesions or to obtain deep sputum samples in complex cases.
94668 - Manipulation chest wall, such as percussion and vibration to facilitate lung function; subsequent
Required for ongoing education and adjustment of airway clearance techniques for chronic management.
94060 - Bronchodilation responsiveness; spirometry as in 94010, pre- and post-bronchodilator administration
Used to determine if the patient has a reversible component to their airway obstruction.
94640 - Pressurized or nonpressurized inhalation treatment for acute airway obstruction or for therapeutic purposes and unit dose nebulizer training
Used to deliver hypertonic saline or bronchodilators during clinic visits or for patient training.
87070 - Culture, bacterial; any other source except urine, blood or stool, with isolation and presumptive identification of isolates
Used to monitor for chronic colonization by pathogens such as Pseudomonas aeruginosa.